Arvinas, Inc. (ARVN)
8.17
-0.23
(-2.74%)
USD |
NASDAQ |
Sep 15, 09:48
Arvinas Market Cap : 533.50M for Sept. 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 14, 2026 | 548.52M |
| September 11, 2026 | 551.78M |
| September 10, 2026 | 568.76M |
| September 09, 2026 | 572.03M |
| September 08, 2026 | 592.92M |
| September 04, 2026 | 613.17M |
| September 03, 2026 | 607.94M |
| September 02, 2026 | 626.23M |
| September 01, 2026 | 605.98M |
| August 31, 2026 | 600.76M |
| August 28, 2026 | 599.45M |
| August 27, 2026 | 603.37M |
| August 26, 2026 | 608.60M |
| August 25, 2026 | 626.88M |
| August 24, 2026 | 609.90M |
| August 21, 2026 | 611.53M |
| August 20, 2026 | 589.33M |
| August 19, 2026 | 632.10M |
| August 18, 2026 | 604.68M |
| August 17, 2026 | 600.76M |
| August 14, 2026 | 585.74M |
| August 13, 2026 | 588.35M |
| August 12, 2026 | 579.21M |
| August 11, 2026 | 587.05M |
| August 10, 2026 | 587.05M |
| Date | Value |
|---|---|
| August 07, 2026 | 571.38M |
| August 06, 2026 | 566.80M |
| August 05, 2026 | 548.52M |
| August 04, 2026 | 587.70M |
| August 03, 2026 | 526.32M |
| July 31, 2026 | 517.94M |
| July 30, 2026 | 535.35M |
| July 29, 2026 | 530.19M |
| July 28, 2026 | 528.90M |
| July 27, 2026 | 530.19M |
| July 24, 2026 | 517.94M |
| July 23, 2026 | 523.74M |
| July 22, 2026 | 532.77M |
| July 21, 2026 | 532.77M |
| July 20, 2026 | 517.29M |
| July 17, 2026 | 516.64M |
| July 16, 2026 | 517.94M |
| July 15, 2026 | 534.06M |
| July 14, 2026 | 533.42M |
| July 13, 2026 | 522.45M |
| July 10, 2026 | 533.42M |
| July 09, 2026 | 550.83M |
| July 08, 2026 | 552.12M |
| July 07, 2026 | 554.06M |
| July 06, 2026 | 545.02M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cocrystal Pharma, Inc. | 16.96M |
| CNBX Pharmaceuticals, Inc. | 0.1476M |
| GB Sciences, Inc. | 0.0814M |
| Fulcrum Therapeutics, Inc. | 287.60M |
| Definium Therapeutics, Inc. | 5.256B |
Market Cap Related Metrics
| PE Ratio | 50.94 |
| PS Ratio | 1.727 |
| Price to Book Value | 0.9490 |
| Price | 8.17 |
| Earnings Yield | 1.96% |
| Normalized PE Ratio | 37.34 |